Biopharmaceutical excipients market seen reaching $5.04 billion by 2030

Nov. 20, 2026
Biopharmaceutical excipients market seen reaching $5.04 billion by 2030
By AI, Created 16:30 UTC, Nov 20, 2026, AGP -

The biopharmaceutical excipients market is projected to grow from $3.57 billion in 2026 to $5.04 billion by 2030, driven by biologic drug development, vaccine demand and newer cell and gene therapy applications. North America held the largest share in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Biopharmaceutical excipients are becoming more important as biologic drugs get more complex and harder to formulate. - The market’s projected growth points to rising demand for ingredients that improve stability, shelf life and delivery in vaccines, biologics and advanced therapies. - The forecast also signals more opportunity for high-purity, multifunctional and therapy-specific excipient products.

What happened: - The Business Research Company released its Biopharmaceutical Excipients Global Market Report 2026. - The report estimates the market will rise from $3.27 billion in 2025 to $3.57 billion in 2026. - The report projects the market will reach $5.04 billion by 2030. - The market is forecast to grow at a 9.0% CAGR from 2026 to 2030.

The details: - Recent growth has been driven by more biologic drug approvals, early use of protein stabilizers, expansion in injectable formulations, vaccine development progress and formulation science improvements. - The report defines biopharmaceutical excipients as inactive ingredients used with active pharmaceutical ingredients to improve development, stability and delivery of biologic drugs. - These excipients do not provide therapeutic effects, but they support safety, efficacy and shelf life. - Common excipient types include sugars, polymers and proteins. - Looking ahead, growth is expected to come from more complex biologic formulations, longer shelf-life requirements, cell and gene therapy expansion, tighter safety scrutiny and greater investment in drug delivery systems. - The report highlights rising demand for high-purity biologic excipients, more multifunctional formulation ingredients, excipients tailored for cell and gene therapies, stability-enhancing compounds and more customized solutions. - The report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technology and future trend analysis, and updated graphics and tables. - Download a free sample of the report. - View the full report.

Between the lines: - Vaccine development remains a key demand driver because excipients help stabilize antigens, improve solubility and preserve product integrity during storage and distribution. - The CDC reported US adolescent vaccination coverage increases from 2022 to 2024 for tetanus, diphtheria and acellular pertussis, meningococcal conjugate and human papillomavirus vaccines. - North America held the largest market share in 2025 because of its advanced biopharmaceutical industry and regulatory environment. - Asia-Pacific is expected to be the fastest-growing region, supported by expanding pharmaceutical manufacturing and higher healthcare investment. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

What's next: - The market is expected to keep expanding through 2030 as biologic pipelines deepen and advanced therapies move closer to commercialization. - Excipient suppliers are likely to focus more on specialized ingredients for stability, purity and delivery performance. - Regional growth is likely to stay strongest in Asia-Pacific as manufacturing capacity and healthcare spending continue to rise.

The bottom line: - Biopharmaceutical excipients are shifting from a supporting ingredient category to a strategic part of biologic drug development, and demand is set to climb steadily through 2030.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Asia News Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.